WaveMan
WaveMan · Company
ARX · Accelerant Holdings
> Search tickers & screens ⌘K
LIVE
← All companies

ARX Accelerant (ARX) Insider Trading, Ownership & Congress Trades

Insurance · Insurance agents, brokers & service · CIK 0001997350
Form 144 · 5
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
82
13F, latest reported quarter

What the filings say about ARX

Insiders, 180 days
-$20.9M net sold
5 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$6.8M
5 notices

Accelerant insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Accelerant Holdings insiders sold a net $20.9M of stock across 36 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
SELL
2026-08-25 SECtraded 2026-08-21
542
$10.6K
+0.8%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Dec 8, 2025.
  • The trade is 2.6% of the 20,868 shares held after it.
  • 4 other insiders sold within 30 days.
  • 82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Meriwether Karen Sue sold about $10.6K of ARX on Aug 21, 2026; 4 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
Director
SELL
2026-08-14 SECtraded 2026-08-13
20,489
$400.8K
+1.4%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (1 buy, 1 sale), the last on Jun 23, 2026.
  • The trade is 1.5% of the 1,341,834 shares held after it.
  • 4 other insiders sold within 30 days.
  • 82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hasley Nancy sold about $400.8K of ARX on Aug 13, 2026; 4 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
Co-Founder, Chief U/W Officer
SELL
2026-08-12 SECtraded 2026-08-11
89,219
$1.1M
+1.6%
Context
  • 10 earlier Form 4 trades (code P or S) here by this insider (1 buy, 9 sales), the last on Aug 10, 2026.
  • The trade is 1.4% of the 6,369,290 shares held after it.
  • 4 other insiders sold within 30 days.
  • 82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Co-Founder, Chief U/W Officer ONeill Francis James sold about $1.1M of ARX on Aug 11, 2026; 4 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
Co-Founder, CEO
SELL
2026-08-11 SECtraded 2026-08-10
80,000
$967.1K
+45.6%
Context
  • 10 earlier Form 4 trades (code P or S) here by this insider (1 buy, 9 sales), the last on Aug 3, 2026.
  • The trade is 0.3% of the 27,591,939 shares held after it.
  • 4 other insiders sold within 30 days.
  • 82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Co-Founder, CEO RADKE JEFFREY L sold about $967.1K of ARX on Aug 10, 2026; 4 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
Co-Founder, Chief U/W Officer
SELL
2026-08-12 SECtraded 2026-08-10
63,616
$767.7K
+1.6%
Context
  • 9 earlier Form 4 trades (code P or S) here by this insider (1 buy, 8 sales), the last on Jul 28, 2026.
  • The trade is 1.0% of the 6,458,509 shares held after it.
  • 4 other insiders sold within 30 days.
  • 82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Co-Founder, Chief U/W Officer ONeill Francis James sold about $767.7K of ARX on Aug 10, 2026; 4 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
36 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 31 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$20.9M over 180 days
-$4.2M over 90 days · -$8.8M of it by a 10%+ holder
below 85% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
82 funds bought in last quarter
below 70% of Insurance
Revenue
+51.5% year over year
more than 90% of Insurance
Margin
-147.4% net margin
below 95% of Insurance
Buybacks
$82.6M repurchased, FY to 2026-06-30
below 64% of Insurance
Short interest
7.9% of the float short (float per yahoo 2026-10-26) · 1.7 days to cover · settled 2026-09-30
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch ARX

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+58.6%12M
-25%+3%+31%+59%2025-102025-122026-022026-042026-062026-082026-10 2026-07-27 · ONeill Francis James sold $1.6M2026-07-28 · ONeill Francis James sold $1.5M2026-07-27 · RADKE JEFFREY L sold $1.2M2026-08-11 · ONeill Francis James sold $1.1M2026-07-20 · RADKE JEFFREY L sold $1.1M2026-07-14 · ONeill Francis James sold $1.1M2026-07-06 · RADKE JEFFREY L sold $1.1M2026-07-13 · RADKE JEFFREY L sold $1.1M2026-07-15 · ONeill Francis James sold $1.1M2026-06-23 · RADKE JEFFREY L sold $1.0M2026-06-29 · RADKE JEFFREY L sold $1.0M2026-06-23 · ONeill Francis James sold $1.0M2025-11-14 · RADKE JEFFREY L bought $999.0K2026-06-26 · ONeill Francis James sold $968.7K2026-08-10 · RADKE JEFFREY L sold $967.1K2026-08-03 · RADKE JEFFREY L sold $964.5K2026-06-25 · ONeill Francis James sold $959.9K2026-06-22 · ONeill Francis James sold $931.8K2026-08-10 · ONeill Francis James sold $767.7K2026-03-23 · Green Jay Michael sold $638.5K2025-11-18 · ONeill Francis James bought $506.9K2026-06-23 · Hasley Nancy sold $458.9K2026-08-13 · Hasley Nancy sold $400.8K2026-07-27 · Sternberg Matthew David sold $257.2K2026-07-27 · RADKE JEFFREY L sold $220.0K2026-07-17 · RADKE JEFFREY L sold $211.3K2025-11-19 · Lee-Smith Christopher bought $197.3K2025-11-19 · Gaynor Samuel bought $100.8K2025-11-17 · Sternberg Matthew David bought $74.7K2026-08-21 · Meriwether Karen Sue sold $10.6K2025-12-08 · Meriwether Karen Sue bought $8.0K2026-08-21 · KAREN MERIWETHER filed to sell $10.6K2026-08-13 · NANCY HASLEY filed to sell $278.9K2026-08-10 · RADKE JEFFREY L filed to sell $958.8K2026-08-10 · Francis James O'Neill filed to sell $4.6M2026-08-03 · RADKE JEFFREY L filed to sell $956.3K2026-07-27 · MATTHEW STERNBERG filed to sell $250.0K2026-07-27 · RADKE JEFFREY L filed to sell $1.4M2026-07-24 · RADKE JEFFREY L filed to sell $424.7K2026-07-20 · RADKE JEFFREY L filed to sell $1.1M2026-07-17 · RADKE JEFFREY L filed to sell $208.7K2026-07-14 · Francis James O'Neill filed to sell $4.8M2026-07-13 · RADKE JEFFREY L filed to sell $1.0M2026-07-06 · RADKE JEFFREY L filed to sell $1.1M2026-06-29 · RADKE JEFFREY L filed to sell $1.0M2026-06-23 · NANCY HASLEY filed to sell $451.1K2026-06-23 · RADKE JEFFREY L filed to sell $1.0M2026-06-23 · Francis James O'Neill filed to sell $2.9M2026-06-22 · Francis James O'Neill filed to sell $947.4K
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns ARX: institutional holders (13F)

13F holdings, latest reported quarter
5,628,679 sh
$66.0M
$54.2M
$46.8M

Congress trades in ARX

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

ARX planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
KAREN MERIWETHER
Filed 2026-08-21
$10.6K
NANCY HASLEY
Filed 2026-08-13
$278.9K
RADKE JEFFREY L
Filed 2026-08-10
$958.8K
Francis James O'Neill
Filed 2026-08-10
$4.6M
RADKE JEFFREY L
Filed 2026-08-03
$956.3K

ARX mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Small Cap Value Fund
$24.7M position · as of 2026-06-30
0.8%
American Century Small Cap Value Insights ETF
$91.0K position · as of 2026-05-31
0.7%
AVIP AB Small Cap Portfolio
$808.2K position · as of 2026-06-30
0.3%
YORKTOWN GROWTH FUND
$270.9K position · as of 2026-07-31
0.2%
SmallCap Growth Fund I
$3.6M position · as of 2026-07-31
0.1%
SMALL CAP EQUITY FUND
$1.2M position · as of 2026-06-30
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $20.9M sold by insiders over 180 days, 82 funds added last quarter, $6.8M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

ARX financials

Revenue growth
+51.5%
XBRL, annual
Net margin
-147.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.1B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-112.1%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
0.17x
long-term debt only, 2026-06-30; equity 2026-06-30
Cash flow to debt
0.38x
TTM operating cash flow over long-term debt only, 2026-06-30
Return on equity
-241.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-15.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
n/a
no share count filed
FCF yield
n/a
no share count filed
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-12
Revenue$912.9M$602.6M$344.0M
Net income-$1.3B$22.9M-$64.1M
EPS (diluted)-7.490.14-0.29
Operating cash flow$445.1M$785.7M$290.0M
Cash$1.7B$1.2B$775.4M
Long-term debt$121.3M$121.4Mn/a
SEC XBRL, fiscal years, as known on 2026-10-27

ARX Stock Sonar score 6/7 axes

Find similar shapesCompare

ARX ranks highest on growth (90th percentile) and financial health (56th), and lowest on profitability (2nd), among Insurance peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
2
Inputs
  • Return on equity-241.6% · 0 pct, sector of 116
  • Return on assets-15.6% · 4 pct, sector of 122
  • Return on invested capitalfewer than four consecutive quarters of operating income
  • Return on capital employedfewer than four consecutive quarters of operating income
Financial health
56
Inputs
  • Debt to equity0.17x · 74 pct, sector of 104
  • Cash flow to debt0.38x · 39 pct, sector of 97
Growth
90
Inputs
  • Revenue growth, YoY+51.5% · 90 pct, sector of 134
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
7
Inputs
  • Net Form 4 buying (codes P and S), 180d-$20.9M · 14 pct, sector of 100
  • Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
30
Inputs
  • Funds adding, latest quarter82 · 30 pct, sector of 108
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
18
Inputs
  • Short interest, % of float+7.9% · 18 pct, sector of 138
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

ARX filings, in plain words

Are Accelerant insiders buying or selling ARX?

In the 180 days to 2026-10-27, Accelerant insiders were net sellers, a net $20.9M across purchases and sales reported on Form 4, by 5 sellers.

Are there planned insider sales of ARX?

Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $6.8M of stock; the latest, by KAREN MERIWETHER, was filed 2026-08-21.

Read the full summary

In the 180 days to 2026-10-27, Accelerant insiders were net sellers of ARX, a net $20.9M across purchases and sales reported on Form 4 by 5 sellers. None of the 24 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $6.8M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing